# Amniotic Fluid Ischemia Modified Albumin as a Novel e Prenatal Diagnostic Marker for Down Syndrome

> **NCT04293380** · NA · COMPLETED · sponsor: **Karadeniz Technical University** · enrollment: 94 (actual)

## Conditions studied

- Down Syndrome
- Prenatal Stress
- Cytokines

## Interventions

- **PROCEDURE:** amniosyntesis

## Key facts

- **NCT ID:** NCT04293380
- **Lead sponsor:** Karadeniz Technical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-01
- **Primary completion:** 2016-06-01
- **Final completion:** 2016-09-01
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2020-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04293380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04293380, "Amniotic Fluid Ischemia Modified Albumin as a Novel e Prenatal Diagnostic Marker for Down Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04293380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*